Request a Quote |

End of Offer Period

Cyprotex PLC ("Cyprotex" or the "Company")

End of bid discussions

The Board of Cyprotex announced on 2 March 2010 that it had received an unsolicited approach regarding a potential offer for the Company. The Board has rejected this approach and discussions are at an end.

This announcement has been made with the agreement of the other party.

For the purposes of the Takeover Code, the Company is no longer in an Offer Period.

Enquiries:

Cyprotex PLC
Steve Harris
Tel: 016 2552 5100
ir@cyprotex.com
www.cyprotex.com

Execution Noble & Company Limited
John Llewellyn-Lloyd
Sam Reynolds
Tel: 020 7456 9191

Public Relations
Financial Dynamics
Ben Brewerton
Ben Atwell
John Dineen
Tel: 020 7831 3113





Contact us

News categories

Archives

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000

 

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:

Close